ストックスクリーナーアプリを入手
59.84
1.58%
-0.89
前日終値:
$60.73
開ける：
$60.72
24時間の取引高:
88,822
Relative Volume:
0.17
時価総額：
$1.76B
収益：
$1.29B
当期純損益:
$131.74M
株価収益率:
14.21
EPS:
4.21
ネットキャッシュフロー:
$166.13M
1週間 パフォーマンス:
+6.90%
1か月 パフォーマンス:
+15.54%
6か月 パフォーマンス:
-20.99%
1年 パフォーマンス:
-17.90%
1日の値動き範囲:
$59.44
$60.85
1週間の範囲:
$54.83
$61.08
52週間の値動き範囲:
$46.00
$78.58
Conmed Corp Stock (CNMD) Company Profile
CNMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
60.02 | 1.76B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
129.37 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.39 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.50 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.33 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.10 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-28 | ダウングレード | Stifel | Buy → Hold |
| 2025-02-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-01 | 繰り返されました | Needham | Buy |
| 2023-05-22 | 開始されました | CL King | Buy |
| 2023-03-27 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-10-06 | アップグレード | Needham | Hold → Buy |
| 2021-07-15 | 開始されました | UBS | Buy |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2019-11-26 | ダウングレード | Needham | Buy → Hold |
| 2019-11-12 | 開始されました | JP Morgan | Overweight |
| 2019-10-31 | 繰り返されました | Needham | Buy |
| 2019-10-04 | 繰り返されました | Needham | Buy |
| 2019-08-22 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | 開始されました | Stifel | Buy |
| 2019-04-16 | 繰り返されました | Needham | Buy |
| 2019-01-23 | 繰り返されました | Needham | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-08-07 | 繰り返されました | Needham | Buy |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-04-26 | 繰り返されました | Needham | Buy |
| 2018-02-01 | 繰り返されました | Needham | Buy |
| 2017-07-27 | 繰り返されました | Needham | Buy |
| 2017-04-27 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | 繰り返されました | Needham | Buy |
| 2016-11-18 | 繰り返されました | Needham | Buy |
| 2016-07-28 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | 繰り返されました | Needham | Buy |
| 2015-10-22 | 繰り返されました | Northland Capital | Market Perform |
すべてを表示
Conmed Corp (CNMD) 最新ニュース
Dean Capital Management Increases Stake in CONMED Co. (NYSE:CNMD) - MarketBeat
First Trust Advisors LP Raises Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Brevan Howard Capital Management LP Grows Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Axa S.A. Raises Position in CONMED Co. (NYSE:CNMD) - MarketBeat
ArrowMark Colorado Holdings LLC Decreases Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Rating Lowered to “Hold” at StockNews.com - Defense World
CONMED Co. (NYSE:CNMD) Stock Holdings Raised by First Trust Advisors LP - Defense World
CONMED Co. (NYSE:CNMD) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Dimensional Fund Advisors LP Has $53.07 Million Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Insider Selling: Charles Farkas Sells 4,000 Shares of Conmed Cor - GuruFocus
PDT Partners LLC Sells 13,579 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED (NYSE:CNMD) Issues Earnings Results - MarketBeat
CONMED (NYSE:CNMD) Given New $61.00 Price Target at Needham & Company LLC - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Earnest Partners LLC Acquires 25,876 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
CONMED Corporation (NYSE:CNMD) Q1 2025 Earnings Call Transcript - Insider Monkey
Conmed (CNMD) Target Price Lowered by Wells Fargo Analyst | CNMD Stock News - GuruFocus
JP Morgan Revises Price Target for Conmed (CNMD) to $58 | CNMD S - GuruFocus
Conmed Corp (CNMD) can make a big difference with a little luck - Sete News
Conmed (CNMD) Analyst Rating Update: Price Target Lowered | CNMD Stock News - GuruFocus
CONMED Corp SEC 10-Q Report - TradingView
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain - GuruFocus
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain Challenges | CNMD Stock News - GuruFocus
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook - Yahoo Finance
Breaking Down Conmed: 6 Analysts Share Their Views - Benzinga
Conmed (CNMD) Target Price Reduced by Wells Fargo Analyst | CNMD Stock News - GuruFocus
CONMED (CNMD) Reports Strong Q1 Revenue Surpassing Estimates | C - GuruFocus
Conmed: Q1 Earnings Snapshot - MySA
Conmed Corp [CNMD] Insider Activity: An Update for Investors - knoxdaily.com
Conmed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: ConMed’s Q1 2025 earnings miss EPS forecasts, stock rises - Investing.com
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump By Investing.com - Investing.com South Africa
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump - Investing.com Canada
CONMED Q1 2025 slides: Revenue growth continues amid GAAP earnings pressure - Investing.com Canada
CONMED Corporation Announces First Quarter 2025 Financial Results - Stock Titan
CONMED (NYSE:CNMD) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED (NYSE:CNMD) Downgraded by Stifel Nicolaus to “Hold” - Defense World
CONMED (CNMD) Downgraded by Stifel Due to Sales Decline - GuruFocus
What To Expect From CONMED’s (CNMD) Q1 Earnings - Barchart.com
Orthopedic Biomaterial Market Overall Study Report 2025-2032 | - openPR.com
Conmed stock rating cut to hold at Stifel, target drops to $55 - Investing.com Canada
Conmed stock rating cut to hold at Stifel, target drops to $55 By Investing.com - Investing.com South Africa
Conmed (CNMD) Downgraded by Stifel Amid Economic Concerns | CNMD Stock News - GuruFocus
CONMED (NYSE:CNMD) Sets New 1-Year LowWhat's Next? - MarketBeat
Natixis Has $7.80 Million Stock Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Fuller & Thaler Asset Management Inc. Takes $59.05 Million Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corp (CNMD) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
0.39%
大文字化:
|
ボリューム (24 時間):